MYOS RENS Technology Company Profile (NASDAQ:MYOS)

About MYOS RENS Technology

MYOS RENS Technology logoMYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MYOS
  • CUSIP:
Key Metrics:
  • Previous Close: $2.74
  • 50 Day Moving Average: $3.3035
  • 200 Day Moving Average: $1.9936
  • 52-Week Range: $1.02 - $6.98
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $13.94M
  • Outstanding Shares: 5,086,000
  • Beta: 1.46
Profitability:
  • Net Margins: -1,466.77%
  • Return on Equity: -87.17%
  • Return on Assets: -68.69%
Debt:
  • Current Ratio: 4.07%
  • Quick Ratio: 2.50%
Additional Links:
Companies Related to MYOS RENS Technology:

Analyst Ratings

Consensus Ratings for MYOS RENS Technology (NASDAQ:MYOS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for MYOS RENS Technology (NASDAQ:MYOS)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for MYOS RENS Technology (NASDAQ:MYOS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/13/2015        
11/17/2014($0.24)($0.73)ViewN/AView Earnings Details
8/14/2014Q214($0.20)($0.34)$1.68 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for MYOS RENS Technology (NASDAQ:MYOS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MYOS RENS Technology (NASDAQ:MYOS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MYOS RENS Technology (NASDAQ:MYOS)
Insider Ownership Percentage: 58.30%
Institutional Ownership Percentage: 2.63%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/23/2016Zhengguang LyuDirectorBuy50,000$1.70$85,000.00View SEC Filing  
9/6/2016Zhengguang LyuDirectorBuy23,505$1.60$37,608.00View SEC Filing  
6/17/2016Zhengguang LyuDirectorBuy10,000$1.65$16,500.00View SEC Filing  
4/8/2016Joseph MannelloDirectorBuy4,417$1.96$8,657.32View SEC Filing  
4/5/2016Joseph MannelloDirectorBuy6,128$1.75$10,724.00View SEC Filing  
9/29/2015Robert J. HaririDirectorBuy2,300$2.68$6,164.00View SEC Filing  
9/25/2015Robert J. HaririDirectorBuy12,150$2.44$29,646.00View SEC Filing  
9/11/2015Robert J. HaririDirectorBuy4,000$1.73$6,920.00View SEC Filing  
9/8/2015Robert J. HaririDirectorBuy25,250$1.71$43,177.50View SEC Filing  
9/4/2015Louis J AronneDirectorBuy5,000$1.76$8,800.00View SEC Filing  
8/28/2015Robert J HaririDirectorBuy2,750$1.74$4,785.00View SEC Filing  
12/4/2014Robert J HaririDirectorBuy2,200$8.16$17,952.00View SEC Filing  
8/18/2014Peter DiamandisDirectorBuy3,444$14.51$49,972.44View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for MYOS RENS Technology (NASDAQ:MYOS)
DateHeadline
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex (NASDAQ:MYOS)
biz.yahoo.com - February 21 at 6:13 PM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri (NASDAQ:MYOS)
us.rd.yahoo.com - February 15 at 2:17 AM
marketwired.com logoMYOS RENS Technology Inc. Adopts Shareholder Rights Plan (NASDAQ:MYOS)
www.marketwired.com - February 14 at 9:13 PM
News IconStock Market Positive Session with Poor Technicals (NASDAQ:MYOS)
marketoracle.co.uk - February 9 at 12:39 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, F (NASDAQ:MYOS)
biz.yahoo.com - February 8 at 7:36 PM
News IconPositive Session with Poor Technicals (NASDAQ:MYOS)
www.fxstreet.com - February 8 at 1:19 AM
finance.yahoo.com logoKey Catalyst That Could Send Biotechs Soaring in 2017: Today's Reports on MYOS RENS Technology and Actinium Pharmaceuticals (NASDAQ:MYOS)
finance.yahoo.com - February 6 at 9:40 AM
us.rd.yahoo.com logo2:55 pm MYOS RENS Tech. commences $2.125 common stock offering; to sell 500k shares at $4.25/share (NASDAQ:MYOS)
us.rd.yahoo.com - February 4 at 5:31 AM
finanznachrichten.de logoMYOS RENS TECHNOLOGY INC (NASDAQ:MYOS)
www.finanznachrichten.de - February 4 at 12:30 AM
streetinsider.com logoMYOS RENS Tech (MYOS) Reports $2.13M Registered Direct Offering of Common Stock (NASDAQ:MYOS)
www.streetinsider.com - February 3 at 7:28 PM
reuters.com logoBRIEF-MYOS RENS TECHNOLOGY ANNOUNCES $2.1 MLN REGISTERED DIRECT OFFERING (NASDAQ:MYOS)
uk.reuters.com - February 3 at 7:28 PM
marketwatch.com logoMYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering (NASDAQ:MYOS)
www.marketwatch.com - February 3 at 7:28 PM
finance.yahoo.com logoDr. Robert Hariri, stem cell pioneer and chairman of MYOS RENS Technology, states that 'healthy muscle is key to overall health and wellness' (NASDAQ:MYOS)
finance.yahoo.com - January 30 at 9:31 AM
4-traders.com logoMYOS RENS Technology : MYOS) Down from Tuesday Gain (NASDAQ:MYOS)
www.4-traders.com - January 25 at 8:15 PM
News IconMarket Drops After Trumps Biotech Pricing Comments, Impressive Come Back (NASDAQ:MYOS)
www.fxstreet.com - January 12 at 12:23 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other (NASDAQ:MYOS)
biz.yahoo.com - January 11 at 7:21 PM
4-traders.com logoMYOS RENS TECHNOLOGY INC. (NASDAQ:MYOS) Files An 8-K Submission of Matters to a Vote of Security Holders (NASDAQ:MYOS)
www.4-traders.com - December 23 at 12:04 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:MYOS)
biz.yahoo.com - December 22 at 7:02 PM
marketexclusive.com logoMYOS RENS TECHNOLOGY INC. (NASDAQ:MYOS) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:MYOS)
marketexclusive.com - November 25 at 11:34 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:MYOS)
biz.yahoo.com - November 25 at 11:34 AM
capitalcube.com logoMYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NASDAQ:MYOS)
www.capitalcube.com - November 18 at 5:56 PM
capitalcube.com logoMYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NASDAQ:MYOS)
www.capitalcube.com - November 18 at 5:56 PM
News IconNew Study: MYOS RENS Technology Inc. (MYOS) - Financial and Strategic SWOT Analysis Review (NASDAQ:MYOS)
reports.pr-inside.com - November 17 at 6:00 PM
News IconNew Study: MYOS RENS Technology Inc. (MYOS) - Financial and Strategic SWOT Analysis Review (NASDAQ:MYOS)
reports.pr-inside.com - November 17 at 6:00 PM
marketwired.com logoMYOS RENS Announces Publication of Its Fortetropin® Human Clinical Trial Manuscript (NASDAQ:MYOS)
www.marketwired.com - September 29 at 11:25 AM
finance.yahoo.com logo8:03 am MYOS RENS Tech. Announces Publication of Fortetropin Human Clinical Trial Manuscript demonstrating that it increased lean body mass, increased muscle thickness, and decreased markers of protein breakdown (NASDAQ:MYOS)
finance.yahoo.com - September 29 at 11:25 AM
publicnow.com logoMYOS RENS Announces Publication of Its Fortetropin(R) Human Clinical Trial Manuscript (NASDAQ:MYOS)
www.publicnow.com - September 29 at 11:25 AM
publicnow.com logoMYOS RENS Technology Inc. Appoints Joseph Mannello as Interim Chief Executive Officer (NASDAQ:MYOS)
www.publicnow.com - September 27 at 10:53 AM
News IconMYOS RENS Tech appoints interim CEO (NASDAQ:MYOS)
www.njbiz.com - September 8 at 6:05 PM
News IconReport explores the 2016 H2 sarcopenia pipeline market outlook research (NASDAQ:MYOS)
www.whatech.com - September 2 at 11:09 AM
reuters.com logoBRIEF-Myos Rens Technology appoints Joseph Mannello interim CEO (NASDAQ:MYOS)
www.reuters.com - August 31 at 11:21 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:MYOS)
biz.yahoo.com - August 24 at 6:07 PM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:MYOS)
biz.yahoo.com - June 29 at 4:17 PM
capitalcube.com logoMYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 (NASDAQ:MYOS)
www.capitalcube.com - June 22 at 11:58 AM
News IconFDA approves minimally invasive AspireAssist weight loss device (NASDAQ:MYOS)
www.healio.com - June 16 at 10:36 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant (NASDAQ:MYOS)
biz.yahoo.com - May 20 at 5:26 PM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MYOS)
biz.yahoo.com - May 13 at 8:34 AM
finance.yahoo.com logoMYOS Reports Positive Results From Fortetropin(R) Clinical Study (NASDAQ:MYOS)
finance.yahoo.com - April 22 at 3:00 PM
capitalcube.com logoMYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:MYOS)
www.capitalcube.com - April 11 at 8:51 AM
capitalcube.com logoMYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:MYOS)
www.capitalcube.com - April 11 at 7:49 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report (NASDAQ:MYOS)
biz.yahoo.com - March 30 at 5:53 PM
publicnow.com logoMYOS Corporation Announces Corporate Name Change to MYOS RENS Technology Inc. (NASDAQ:MYOS)
www.publicnow.com - March 23 at 5:21 AM
biz.yahoo.com logoMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ (NASDAQ:MYOS)
biz.yahoo.com - March 22 at 4:33 PM
biz.yahoo.com logoMYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Cha (NASDAQ:MYOS)
biz.yahoo.com - March 8 at 5:31 PM
finance.yahoo.com logoMYOS Corporation Announces Election of New Directors and Appointment of Ren Ren as Global Chairman (NASDAQ:MYOS)
finance.yahoo.com - March 8 at 4:17 PM
News IconRheumatoid arthritis market pipeline review H2 2015 published by leading research firm (NASDAQ:MYOS)
www.whatech.com - February 12 at 2:47 PM
biz.yahoo.com logoMYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:MYOS)
biz.yahoo.com - February 4 at 5:21 PM
capitalcube.com logoMYOS Corp. – Value Analysis (NASDAQ:MYOS) : November 3, 2015 (NASDAQ:MYOS)
www.capitalcube.com - November 3 at 12:08 PM
noodls.com logoMaintaining Muscle Linked to Preserving Healthy Brain Tissue (NASDAQ:MYOS)
www.noodls.com - October 26 at 7:55 AM
noodls.com logoMYOS' Proprietary Muscle Building Technology Fortetropin: Foundation for New Dietary Recommendations (NASDAQ:MYOS)
www.noodls.com - October 19 at 7:51 AM

Social

What is MYOS RENS Technology's stock symbol?

MYOS RENS Technology trades on the NASDAQ under the ticker symbol "MYOS."

When will MYOS RENS Technology announce their earnings?

MYOS RENS Technology is scheduled to release their next quarterly earnings announcement on Friday, November, 13th 2015.

How do I buy MYOS RENS Technology stock?

Shares of MYOS RENS Technology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of MYOS RENS Technology stock cost?

One share of MYOS RENS Technology stock can currently be purchased for approximately $2.74.

MYOS RENS Technology (NASDAQ:MYOS) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for MYOS RENS Technology (NASDAQ:MYOS)

Earnings History Chart

Earnings by Quarter for MYOS RENS Technology (NASDAQ:MYOS)

Dividend History Chart

Dividend Payments by Quarter for MYOS RENS Technology (NASDAQ:MYOS)

Last Updated on 2/24/2017 by MarketBeat.com Staff